Topic

Q-Line Biotech

1 recent story · updated continuously

Moneycontrol

Q-Line Biotech IPO Sees Record 95x Subscription Amid Tepid Interest for Other Public Issues

businessJust now
Q-Line Biotech IPO Sees Record 95x Subscription Amid Tepid Interest for Other Public Issues